|
| 36572064 | Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management. | J Am Acad Dermatol | 2024 |
| 37584292 | Red cell distribution width as a new prognostic biomarker in refractory chronic graft-<i>versus</i>-host disease. | Haematologica | 2024 |
| 36572065 | Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations. | J Am Acad Dermatol | 2024 |
| 36572064 | Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management. | J Am Acad Dermatol | 2024 |
| 37584292 | Red cell distribution width as a new prognostic biomarker in refractory chronic graft-<i>versus</i>-host disease. | Haematologica | 2024 |
| 36572065 | Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations. | J Am Acad Dermatol | 2024 |
| 36116509 | Counting Monkeypox Lesions in Patient Photographs: Limits of Agreement of Manual Counts and Artificial Intelligence. | J Invest Dermatol | 2023 |
| 36370903 | Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial. | J Am Acad Dermatol | 2023 |
| 36116509 | Counting Monkeypox Lesions in Patient Photographs: Limits of Agreement of Manual Counts and Artificial Intelligence. | J Invest Dermatol | 2023 |
| 37738626 | Natural history study of patients with familial platelet disorder with associated myeloid malignancy. | Blood | 2023 |
| 37561579 | A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome. | J Clin Invest | 2023 |
| 37684526 | Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease. | Bone Marrow Transplant | 2023 |
| 37474729 | Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease. | Bone Marrow Transplant | 2023 |
| 36513625 | A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening. | Am J Med Genet A | 2023 |
| 36504258 | Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. | J Clin Immunol | 2023 |
| 37331486 | PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma. | Urology | 2023 |
| 36757705 | Mpox-A Rapidly Evolving Disease. | JAMA Dermatol | 2023 |
| 37132021 | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report. | J Investig Med High Impact Case Rep | 2023 |
| 36746554 | Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. | Br J Dermatol | 2023 |
| 37561579 | A phase III randomized crossover trial of plerixafor versus G-CSF for treatment of WHIM syndrome. | J Clin Invest | 2023 |
| 37738626 | Natural history study of patients with familial platelet disorder with associated myeloid malignancy. | Blood | 2023 |
| 37684526 | Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease. | Bone Marrow Transplant | 2023 |
| 37132021 | Non-cirrhotic Portal Hypertension as the Initial Presentation of Limited Cutaneous Scleroderma: A Case Report. | J Investig Med High Impact Case Rep | 2023 |
| 37474729 | Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease. | Bone Marrow Transplant | 2023 |
| 37331486 | PRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell Carcinoma. | Urology | 2023 |
| 36746554 | Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society. | Br J Dermatol | 2023 |
| 36513625 | A diagnosis of Birt-Hogg-Dubé syndrome in individuals with Smith-Magenis syndrome: Recommendation for cancer screening. | Am J Med Genet A | 2023 |
| 36504258 | Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome. | J Clin Immunol | 2023 |
| 36757705 | Mpox-A Rapidly Evolving Disease. | JAMA Dermatol | 2023 |
| 36370903 | Reply-Response to Anakinra for refractory pustular psoriasis: A phase II, open label, dose-escalation trial. | J Am Acad Dermatol | 2023 |
| 35262093 | Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. | medRxiv | 2022 |
| 35653263 | Pernio and early SARS-CoV-2 variants: natural history of a prospective cohort and the role of interferon. | Br J Dermatol | 2022 |
| 36223107 | Anakinra-Associated Amyloidosis. | JAMA Dermatol | 2022 |
| 36348353 | Collection of peripheral blood mononucleated cells for chronic graft-versus-host disease immunology research: safety and effectiveness of leukapheresis in 132 patients. | J Transl Med | 2022 |
| 35747850 | Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease. | Hemasphere | 2022 |
| 35868845 | Gain-of-function mutations in <i>ALPK1</i> cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. | Ann Rheum Dis | 2022 |
| 35793467 | Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. | Blood | 2022 |
| 36116584 | Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial. | J Am Acad Dermatol | 2022 |
| 35852866 | Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. | JCI Insight | 2022 |
| 33495304 | <i>DDX58</i>(RIG-I)-related disease is associated with tissue-specific interferon pathway activation. | J Med Genet | 2022 |
| 35189151 | Fibroblasts from Patients with Melorheostosis Promote Angiogenesis in Healthy Endothelial Cells through Secreted Factors. | J Invest Dermatol | 2022 |
| 35114411 | Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. | Transplant Cell Ther | 2022 |
| 35095905 | The Spectrum of the Deficiency of Adenosine Deaminase 2: An Observational Analysis of a 60 Patient Cohort. | Front Immunol | 2022 |
| 34878490 | It Is Time to Focus on Pustular Psoriasis. | JAMA Dermatol | 2022 |
| 35262093 | Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. | medRxiv | 2022 |
| 35653263 | Pernio and early SARS-CoV-2 variants: natural history of a prospective cohort and the role of interferon. | Br J Dermatol | 2022 |
| 35793467 | Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. | Blood | 2022 |
| 35852866 | Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. | JCI Insight | 2022 |
| 35747850 | Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host Disease. | Hemasphere | 2022 |
| 35868845 | Gain-of-function mutations in <i>ALPK1</i> cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. | Ann Rheum Dis | 2022 |